Technologies
PDF


WARF: P99313US

Detecting Microscopic Pathogens with Liquid Crystals


INVENTORS -

Nicholas Abbott, Justin Skaife

The Wisconsin Alumni Research Foundation (WARF) is seeking commercial partners interested in developing a liquid crystal-based device for simple, efficient and accurate detection of pathogenic microbes.
OVERVIEWMany methods exist for detecting viral and bacterial pathogens in environmental and clinical samples, including conventional assays such as ELISA (enzyme-linked immunosorbent assay), as well as more recent advances such as surface plasmon reflectometry (SPR). Although these techniques work well for determining the presence of pathogens, they also require expensive, complex laboratory equipment and/or highly trained personnel.
THE INVENTIONUW-Madison researchers have developed a liquid crystal-based device for simple, efficient and accurate detection of pathogenic microbes. The device consists of a micro-structured surface containing depressions that match the size and contours of a specific bacterial species or viral type. The surface is also treated to bind a specific pathogen of interest and to block non-specific binding.

When the substrate is exposed to a water or soil sample from the field, the pathogen, if present, attaches to the surface and occupies the depressions. Next, a liquid crystal surface is laid over the micro-structured surface. If the pathogen is present, the liquid crystal layer will respond by changing its color or brightness, allowing easy visual read-out by an observer. In the absence of the pathogen, the liquid crystal layer appears dark. The device surface may also be designed as an array, so that clinical or environmental samples can be probed for multiple pathogens simultaneously.
APPLICATIONS
  • Pathogen detection
KEY BENEFITS
  • Offers rapid and accurate pathogen detection, enabling informed decision-making at the earliest stages of a public health emergency
  • May be used in the field without the need for specialized laboratory equipment
  • Requires minimal training of personnel
  • Provides accurate results in much less time than conventional, serological tests, such as ELISA
  • Offers ability to screen for several pathogens at once
  • May be used to screen for a wide array of microscopic organisms, including bacteria such as E. coli and Mycobacterium tuberculosis, viruses such as West Nile and the foot and mouth disease virus, and other pathogens like cryptosporidium
  • Could potentially allow identification of target tissues and routes of entry for weaponized, recombinant microbes faster than genetic analyses
  • Could be used as a rapid screening technique prior to more complex pathogen detection analyses
Contact Information
For current licensing status, please contact Jennifer Gottwald at jennifer@warf.org or 608-960-9854.
The WARF Advantage

Since its founding in 1925 as the patenting and licensing organization for the University of Wisconsin-Madison, WARF has been working with business and industry to transform university research into products that benefit society. WARF intellectual property managers and licensing staff members are leaders in the field of university-based technology transfer. They are familiar with the intricacies of patenting, have worked with researchers in relevant disciplines, understand industries and markets, and have negotiated innovative licensing strategies to meet the individual needs of business clients.